MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Tag: prediabetes

prediabetes

Latest news

Tag

Diabetes & Endocrinology

Baseline Plasma Metabolites Predict Long-Term Glycemic Outcomes in Prediabetes: Insights from the PROP-ABC Study

This study identifies baseline plasma metabolites, specifically 2hr plasma glucose and ceramide C18:0/C18:1 ratio, as predictors of persistent prediabetes vs. normoglycemia following lifestyle intervention over 5 years.

Oct 5, 2026
Diabetes & Endocrinology

Metabolic Status Influences Bone Response to Active Vitamin D in Prediabetes: Insights from the DPVD Trial

Metabolic status, reflected by glycemic trajectories, significantly modifies the skeletal response to active vitamin D analog eldecalcitol, with greater BMD improvements observed in individuals regressing from prediabetes to normoglycemia.

Oct 4, 2026
Clinical Updates

Differential Physical Activity Responses to Diabetes Risk Reduction Interventions According to Prediabetes Phenotype: Insights from Pooled Randomized Controlled Trials

The effectiveness of lifestyle interventions promoting physical activity for diabetes risk reduction varies by prediabetes phenotype, with individuals having impaired fasting glucose showing the least response. Tailored approaches may enhan

Sep 16, 2026Sign in to read
Diabetes & Endocrinology

Metabolic Implications of Hepatic, Pancreatic, and Abdominal Fat Depots in Asian Indians Across Normoglycaemia, Prediabetes, and Type 2 Diabetes

This study reveals that Asian Indians with prediabetes or type 2 diabetes show significantly higher liver and abdominal fat despite similar BMI, highlighting liver fat’s key role in dysglycaemia and the importance of early interventio

Aug 3, 2026
Diabetes & Endocrinology

Air Pollution and Built Environment Linked to Prediabetes Incidence and Remission in KORA Study

Long-term exposure to particulate matter and lack of green space were associated with increased risk of prediabetes, especially impaired glucose tolerance phenotypes, and reduced remission of isolated impaired fasting glucose.

Jul 28, 2026
Diabetes & Endocrinology

Semaglutide Improves Insulin Sensitivity in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial

In a 30-week randomized trial, semaglutide improved insulin sensitivity, reduced insulin resistance, lowered fasting glucose, and produced substantial weight loss in patients with schizophrenia and prediabetes taking second-generation antip

May 26, 2026Sign in to read
Diabetes & Endocrinology

Children Born SGA Receiving Growth Hormone Have Similarly Impaired Glucose-Insulin Metabolism as Children With Obesity

Children born SGA receiving growth hormone showed insulin resistance and prediabetes rates similar to obesity, suggesting the need for careful glucose monitoring during and after treatment.

May 19, 2026
Diabetes & Endocrinology

Improving the Algorithm: Adding a Socioeconomic Measure to Predict Type 2 Diabetes in Youth With Prediabetes

Adding the Area Deprivation Index to HbA1c improved prediction of type 2 diabetes within 1 year in youth with prediabetes, highlighting the importance of socioeconomic factors in diabetes risk.

May 16, 2026
Diabetes & Endocrinology

Staging Intermediate Hyperglycaemia to Improve Type 2 Diabetes Prevention: Findings from the ELSA-Brasil Study

The ELSA-Brasil study found that staging intermediate hyperglycaemia with fasting glucose plus 1-hour glucose better predicted type 2 diabetes than fasting glucose plus HbA1c, and a clinical risk score reduced unnecessary testing.

May 13, 2026
Diabetes & Endocrinology

Early Antenatal Prediabetes: A Critical Red Flag for Rapid Postpartum Progression to Type 2 Diabetes

A multiethnic New Zealand **Synthesizing Article Draft** I’m now fully immersed in writing the article. I’m focusing on the “Introduction/Highlight,” integrating the essential findings regarding HbA1c, BMI, and Pacif

Mar 10, 2026
Cardiology

Prediabetes and Silent Cardiac Injury: A High-Risk Synergy for Heart Failure in Hypertensive Patients

A post hoc analysis of the SPRINT trial reveals that the coexistence of prediabetes and subclinical myocardial injury or stress significantly escalates heart failure risk in hypertensive adults, suggesting a need for integrated glycemic and

Jan 17, 2026
Diabetes & Endocrinology

Beyond the High-Protein Hype: Why Moderate Diets May Be the Secret to Reversing Prediabetes

A major long-term trial reveals that a moderate-protein, moderate-glycaemic index diet is more effective for sustaining prediabetes remission than high-protein alternatives, regardless of total weight loss.

Jan 10, 2026
Cardiology

Tirzepatide Lowers 10‑Year Predicted Risk of Cardiovascular Disease and Type 2 Diabetes in Adults with Obesity and Prediabetes: Post hoc Analysis of SURMOUNT‑1

A post hoc analysis of the three‑year SURMOUNT‑1 trial found that once‑weekly tirzepatide (5–15 mg) produced dose‑dependent reductions in 10‑year predicted risks for ASCVD, heart failure, total CVD and progression to type 2 diabetes versus

Dec 5, 2025
Diabetes & Endocrinology

Prediabetes Pathways: Age-Driven Trajectories to Type 2 Diabetes, Cancer, and Death in 328,000 Adults — What Clinicians Need to Know

A 20-year multistate analysis of 328,049 adults with prediabetes in England shows age strongly shapes progression to type 2 diabetes, cancer, and death, with younger patients likely to remain in prediabetes—highlighting windows for tailored

Nov 24, 2025
Superintelligence

Stepped Care Plus Cash Incentives Cuts 3‑Year Diabetes Incidence in Multiethnic Asian Prediabetes Cohort

The Pre-DICTED randomized trial found a stepped-care diabetes prevention program augmented with financial incentives reduced 3‑year diabetes conversion (34.8% vs 47.3%; adjusted RR 0.74), with metformin added for persistent high-risk partic

Nov 17, 2025Sign in to read
Diabetes & Endocrinology

Prediabetes Remission Without Weight Loss: Rethinking Targets to Prevent Type 2 Diabetes

A post hoc analysis of PLIS and replication in the DPP show that achieving prediabetes remission—normalization of glucose—can prevent type 2 diabetes even without net weight loss, via improved insulin sensitivity, β‑cell function and favora

Nov 12, 2025Sign in to read
Diabetes & Endocrinology

Rethinking Prediabetes: Controlling Blood Sugar Without Losing Weight Shows Promise

A groundbreaking study reveals that lifestyle changes improving fat distribution and insulin function can reverse prediabetes without weight loss, significantly cutting type 2 diabetes risk.

Nov 1, 2025
Superintelligence

Evaluating AI-Led vs Human-Led Lifestyle Interventions in Prediabetes: Evidence from a Randomized Clinical Trial of the Diabetes Prevention Program

This review examines the first phase 3 randomized trial demonstrating that an AI-powered Diabetes Prevention Program lifestyle intervention is noninferior to human coaching in improving weight loss, HbA1c, and physical activity among adults

Oct 29, 2025Sign in to read
Diabetes & Endocrinology

Semaglutide for Metabolic Health in Schizophrenia: Insights from the HISTORI RCT

The HISTORI trial demonstrates that semaglutide significantly improves glycemic control, reduces weight, and enhances physical quality of life in schizophrenia patients treated with second-generation antipsychotics, without worsening psychi

Oct 22, 2025
Diabetes & Endocrinology

Hydroxytyrosol Supplementation Enhances Antioxidant and Anti-Inflammatory Status in Overweight Prediabetic Adults: Insights from a Randomized Controlled Trial

A 16-week randomized trial demonstrates that daily hydroxytyrosol supplementation significantly reduces oxidative stress and inflammatory markers in overweight individuals with prediabetes, highlighting its potential in preventing aging-rel

Sep 17, 2025
1 / 2
12
Next

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story